HomeREGULATORY
REGULATORY

Reimbursement Policies for CAR-T, Other Pricey Drugs Might Come Up for Discussion on Oct. 10
(Oct.5.2018)

The Social Security Council, a health ministry advisory organ for broad social insurance policymaking, is to take up the topic of reimbursement policies for new drugs on October 10, with members possibly to discuss the handling of CAR-T cell therapies as a decision draws near for one such product by Novartis ...
(LOG IN FOR FULL STORY)